Zobrazeno 1 - 10
of 202
pro vyhledávání: '"Maureen Power"'
Autor:
Tamzin Furtado, Samuel Franzen, Francois van Loggerenberg, Gwenaelle Carn, Shannon Grahek, Megan McBride, Maureen Power, Jennifer O'Reilly, Barbara Savarese, Margaret Ann Snowden, Gwynn Stevens, Almarie Uys, Trudie Lang
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 8, Iss 11, p e3225 (2014)
Externí odkaz:
https://doaj.org/article/771c08bec9f44df8bd3a9349b065abad
Autor:
Shabir A. Madhi, Michelle J. Groome, Alan Fix, Nicola Page, Anthonet Koen, Maureen Power, Iksung Cho, Stanley J. Cryz, Monica M. McNeal, Jorge Flores, Lee Fairlie, Maysseb Masenya, Julie Morrison, Lisa Jose, Len Dally
Publikováno v:
The Lancet Infectious Diseases
The Lancet. Infectious Diseases
The Lancet. Infectious Diseases
Summary Background A monovalent, parenteral, subunit rotavirus vaccine was well tolerated and immunogenic in adults in the USA and in toddlers and infants in South Africa, but elicited poor responses against heterotypic rotavirus strains. We aimed to
Autor:
Igor Losev, Petukhova Gd, Alexandra Nikiforova, Marina Stukova, Donina Sa, Irina Isakova-Sivak, Anatoly Naykhin, Larisa Rudenko, Maureen Power, Mariana Erofeeva, Daniil Korenkov, Jorge Flores
Publikováno v:
Human Vaccines & Immunotherapeutics
During the past decade, a number of H5 subtype influenza vaccines have been developed and tested in clinical trials, but most of them induced poor serum antibody responses prompting the evaluation of novel vaccination approaches. One of the most prom
Autor:
Ho Vinh Thang, Kathleen M. Neuzil, Le Van Be, Nguyen Phu Cuong, Nguyen Tuyet Nga, Maureen Power, Cao Bao Van, Vu Minh Huong, John C. Victor, Jorge Flores, Vadim Tsvetnitsky
Publikováno v:
Vaccine. 36(46)
We tested a new A/H1N1 inactivated influenza vaccine (IIV) manufactured by Institute of Vaccines and Medical Biologics (IVAC), Vietnam in 48 adults in a Phase 1, double-blinded, randomized, placebo-controlled trial. Two doses of unadjuvanted vaccine
Autor:
Jorge Flores, Alexandra Nikiforova, Maria Pisareva, Tatiana Smolonogina, Maureen Power, Irina Dubrovina, Victoria Kuznetsova, Anatoly Naykhin, Larisa Rudenko, Donina Sa, Mariana Erofeeva, Petukhova Gd, Marina Stukova, Irina Isakova-Sivak, Irina Kiseleva
Publikováno v:
Human Vaccines & Immunotherapeutics. 11:970-982
H2N2 influenza viruses have not circulated in the human population since 1968, but they are still being regularly detected in the animal reservoir, suggesting their high pandemic potential. To prepare for a possible H2N2 pandemic, a number of H2N2 va
Autor:
Prasad S, Kulkarni, Sajjad, Desai, Tushar, Tewari, Anand, Kawade, Nidhi, Goyal, Bishan Swarup, Garg, Dinesh, Kumar, Suman, Kanungo, Veena, Kamat, Gagandeep, Kang, Ashish, Bavdekar, Sudhir, Babji, Sanjay, Juvekar, Byomkesh, Manna, Shanta, Dutta, Rama, Angurana, Deepika, Dewan, Abhijeet, Dharmadhikari, Jagdish K, Zade, Rajeev M, Dhere, Alan, Fix, Maureen, Power, Vidyasagar, Uprety, Varsha, Parulekar, Iksung, Cho, Temsunaro R, Chandola, Vikash K, Kedia, Abhishek, Raut, Jorge, Flores, Chythra V, Raj
Publikováno v:
Vaccine
Highlights • Pentavalent reassortant rotavirus vaccine was tested for efficacy in infants. • The vaccine (BRV-PV) showed excellent tolerability and a good safety profile. • Primary analysis efficacy was 36% against SRVGE and up to 60.5% against
Autor:
Lei Zhang, Amy Sarah Ginsburg, Jorge Flores, Stephen P. Luby, Mukesh Bhardwaj, Mahmudur Rahman, Susan L. Hills, Abu Mohd Naser, Mansour Yaich, K. Zaman, Maureen Power
Publikováno v:
Vaccine. 32:6061-6066
We conducted a four-arm, double-blind, randomized controlled trial among 818 Bangladeshi infants between 10 and 12 months of age to establish equivalence among three lots of live attenuated SA 14-14-2 JE vaccine manufactured by the China National Bio
Autor:
Nicola Page, Alan Fix, Michelle J. Groome, Monica M. McNeal, Maureen Power, Lisa Jose, Shabir A. Madhi, Stanley J. Cryz, Len Dally, Anthonet Koen, Iksung Cho, Jorge Flores
Publikováno v:
The Lancet. Infectious diseases
Efficacy of live oral rotavirus vaccines is reduced in low-income compared with high-income settings. Parenteral non-replicating rotavirus vaccines might offer benefits over oral vaccines. We assessed the safety and immunogenicity of the P2-VP8-P[8]
Publikováno v:
BJOG: An International Journal of Obstetrics and Gynaecology. 110:281-286
Objective To evaluate the performance of a one-stop multidisciplinary clinic of screening for fetal chromosomal anomalies in the first trimester of pregnancy by a combination of maternal serum biochemistry and ultrasonography. Design Retrospective re
Autor:
Almarie Uys, Gwenaelle Carn, Tamzin Furtado, Samuel R P Franzen, Maureen Power, Jennifer O'Reilly, Francois van Loggerenberg, Megan McBride, Gwynn Stevens, Trudie Lang, Margaret Ann Snowden, Barbara Savarese, Shannon Grahek
Publikováno v:
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 8, Iss 11, p e3225 (2014)
PLoS Neglected Tropical Diseases, Vol 8, Iss 11, p e3225 (2014)
1 The Global Health Network, Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom, 2 Drugs for Neglected Disease Initiative (DNDi), Geneva, Switzerland, 3 Department of